RU2015139557A - Уменьшение риска развития аутоимунного заболевания - Google Patents
Уменьшение риска развития аутоимунного заболевания Download PDFInfo
- Publication number
- RU2015139557A RU2015139557A RU2015139557A RU2015139557A RU2015139557A RU 2015139557 A RU2015139557 A RU 2015139557A RU 2015139557 A RU2015139557 A RU 2015139557A RU 2015139557 A RU2015139557 A RU 2015139557A RU 2015139557 A RU2015139557 A RU 2015139557A
- Authority
- RU
- Russia
- Prior art keywords
- hydrolyzate
- autoimmune disease
- seq
- group
- nutritional composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Obesity (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (13)
1. Способ уменьшения риска развития аутоиммунного заболевания, лечения аутоиммунного заболевания и/или уменьшения симптомов аутоиммунного заболевания у субъекта путем введения субъекту композиции, содержащей гидролизат казеина, причем гидролизат состоит из пептидов с молекулярной массой более 500 Да.
2. Способ по п. 1, причем аутоиммунное заболевание выбрано из группы, состоящей из сахарного диабета 1-го типа, болезни Крона, язвенного колита, метаболического синдрома, заболеваний, связанных с HLA-DQ8, заболеваний, связанных с HLA-DQ2, и целиакии.
3. Способ по п. 2, причем аутоиммунное заболевание представляет собой сахарный диабет 1-го типа.
4. Способ по п. 1, причем гидролизат содержит по меньшей мере три пептида, выбранных из группы, состоящей из SEQ ID NO: 1-68.
5. Способ по п. 4, причем гидролизат содержит по меньшей мере три пептида, выбранных из группы, состоящей из SEQ ID NO: 1-24.
6. Способ по п. 5, причем гидролизат содержит по меньшей мере три пептида, выбранных из группы, состоящей из SEQ ID NO: 1-15.
7. Способ по п. 4, причем гидролизат содержит пептид с SEQ ID NO: 1 и по меньшей мере три пептида, выбранных из группы, состоящей из SEQ ID NO: 2-68.
8. Способ по п. 1, причем гидролизат вводят в питательную композицию, содержащую липидную или жировую фазу и источник белков.
9. Способ по п. 8, причем питательная композиция содержит от приблизительно 0,1 до приблизительно 1 г/100 ккал пребиотической композиции, причем пребиотическая композиция содержит по меньшей мере 20% олигосахарида.
10. Способ по п. 8, причем питательная композиция дополнительно содержит от приблизительно 5 до приблизительно 100 мг/100 ккал источника длинноцепочечных полиненасыщенных жирных кислот, который содержит докозагексаеновую кислоту.
11. Способ по п. 10, причем питательная композиция дополнительно содержит арахидоновую кислоту.
12. Способ по п. 1, причем субъект представляет собой ребенка или подростка.
13. Способ по п. 1, причем питательный состав дополнительно содержит один или несколько углеводов, нуклеиновых кислот, липидов, минералов, анаболических питательных веществ, витаминов, антиоксидантов, пробиотических бактериальных штаммов и липотропных веществ.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/839,212 US9289461B2 (en) | 2013-03-15 | 2013-03-15 | Reducing the risk of autoimmune disease |
| US13/839,212 | 2013-03-15 | ||
| PCT/US2014/023630 WO2014150566A1 (en) | 2013-03-15 | 2014-03-11 | Reducing the risk of autoimmune disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2015139557A true RU2015139557A (ru) | 2017-05-02 |
Family
ID=50483516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015139557A RU2015139557A (ru) | 2013-03-15 | 2014-03-11 | Уменьшение риска развития аутоимунного заболевания |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9289461B2 (ru) |
| EP (1) | EP2968438A1 (ru) |
| CN (1) | CN105073126A (ru) |
| AR (1) | AR095335A1 (ru) |
| AU (1) | AU2014237022A1 (ru) |
| BR (1) | BR112015017909A2 (ru) |
| CA (1) | CA2905817A1 (ru) |
| HK (1) | HK1216994A1 (ru) |
| MX (1) | MX2015011927A (ru) |
| PE (1) | PE20152003A1 (ru) |
| PH (1) | PH12015502100B1 (ru) |
| RU (1) | RU2015139557A (ru) |
| SG (1) | SG11201505692QA (ru) |
| TW (1) | TW201521756A (ru) |
| WO (1) | WO2014150566A1 (ru) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10251928B2 (en) | 2014-11-06 | 2019-04-09 | Mead Johnson Nutrition Company | Nutritional supplements containing a peptide component and uses thereof |
| US20170020950A1 (en) * | 2015-07-23 | 2017-01-26 | Mead Johnson Nutrition Company | Methods for modulating kinases |
| AU2017261723B2 (en) | 2016-05-11 | 2023-02-09 | University Of Southern California | Fasting mimicking diet (FMD) as an immunoregulatory treatment for gastrointestinal autoimmune/inflammatory diseases. |
| AU2017394032B8 (en) | 2017-01-21 | 2020-10-22 | Guangzhou Hanfang Pharmaceutical Co., Ltd. | Use of paeoniflorin-6'-o-benzenesulfonate in treatment of sjögren's syndrome |
| CN117384270B (zh) * | 2023-10-13 | 2024-07-16 | 华南理工大学 | 一种酪蛋白源dpp-iv抑制六肽及其制备方法与应用 |
Family Cites Families (106)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2064092C2 (de) | 1970-12-28 | 1983-06-01 | Bayer Ag, 5090 Leverkusen | Inhibitoren für Glykosidhydrolasen aus Actinomyceten |
| US3937817A (en) | 1973-02-28 | 1976-02-10 | Bayer Aktiengesellschaft | Pharmaceutical compositions containing a saccharase inhibitor |
| US4016260A (en) | 1974-07-22 | 1977-04-05 | Toyama Chemical Co., Ltd. | Novel polypeptide produced by pseudomonas |
| FR2474828B1 (fr) | 1980-02-01 | 1983-09-09 | Agronomique Inst Nat Rech | Procede de traitement d'une matiere premiere a base de caseine, contenant des phosphocaseinates de cations bivalents, produits obtenus et application |
| FR2474829B1 (fr) | 1980-02-01 | 1983-09-09 | Agronomique Inst Nat Rech | Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications |
| US4491589A (en) | 1982-05-17 | 1985-01-01 | The Trustees Of Columbia University In The City Of New York | Amino acid solutions for parenteral nutrition and methods of formulation and use |
| DK589785A (da) | 1985-12-18 | 1987-06-19 | Samuelsson Ernst Gunnar | Peptidpraeparat, fremgangsmaade til fremstilling deraf samt anvendelse af peptidpraeparatet |
| IT1190349B (it) | 1986-06-16 | 1988-02-16 | Prodotti Formenti Srl | Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle |
| FR2608050B1 (fr) | 1986-12-15 | 1990-04-13 | Bellon Labor Sa Roger | Procede de preparation d'un melange peptidique riche en di- et tri-peptides, utilisable notamment en nutrition artificielle et en dietetique, melange ainsi obtenu, et utilisation de ce melange en nutrition artificielle et en dietetique |
| US5230902A (en) | 1988-04-29 | 1993-07-27 | Immunotec Research Corporation | Undenatured whey protein concentrate to improve active systemic humoral immune response |
| US5102871A (en) | 1989-04-24 | 1992-04-07 | Kyowa Hakko Kogyo Co., Ltd. | Nutrient composition |
| FI904074A0 (fi) | 1989-08-28 | 1990-08-17 | Milupa Ag | Protein-, peptid- och aminosyrablandningar med optimerad aminosyrasammansaettning samt deras anvaendning foer framstaellning av naering foer prematur- och dibarn samt av tillsatser till modersmjoelk. |
| US5407957A (en) | 1990-02-13 | 1995-04-18 | Martek Corporation | Production of docosahexaenoic acid by dinoflagellates |
| PH30997A (en) | 1990-03-12 | 1997-12-23 | Ciba Geigy | Antipathologenically effective compositions comprising lytic peptides and hydrolytic enzymes. |
| ZA92452B (en) | 1991-01-24 | 1992-10-28 | Martek Corp | Microbial oil mixtures and uses thereof |
| US5308832A (en) | 1992-07-27 | 1994-05-03 | Abbott Laboratories | Nutritional product for persons having a neurological injury |
| GB9310472D0 (en) | 1993-05-20 | 1993-07-07 | Univ Warwick | Phenylalanine-free protein and dna coding thereof |
| GB9312369D0 (en) | 1993-06-16 | 1993-07-28 | Sandoz Nutrition Ltd | Organic compounds |
| US5405637A (en) * | 1993-06-30 | 1995-04-11 | Bristol-Myers Squibb Company | Milk protein partial hydrolysate and infant formula containing same |
| US5714472A (en) | 1993-12-23 | 1998-02-03 | Nestec Ltd. | Enternal formulation designed for optimized nutrient absorption and wound healing |
| US5723446A (en) | 1993-12-23 | 1998-03-03 | Nestec Ltd. | Enteral formulation designed for optimized nutrient absorption and wound healing |
| US5605893A (en) | 1994-03-15 | 1997-02-25 | Children's Hospital Of Los Angeles | Method of using a therapeutic food composition to diminish blood sugar fluctuations in diabetic patients |
| US5643880A (en) | 1994-05-26 | 1997-07-01 | Abbott Laboratories | Product for inhibition of attachment of H. influenzae to human cells |
| DE69536000D1 (de) | 1994-11-04 | 2009-10-22 | A2 Corp Ltd | Selektionsverfahren für nicht-diabetogene milch oder milchprodukte sowie hierdurch erfasste milch oder milchprodukte |
| US5821217A (en) | 1995-10-27 | 1998-10-13 | Beth Israel Deaconess Medical Center, Inc. | Enteral formulation: low in fat and containing protein hydrolysates |
| IT1277964B1 (it) | 1995-12-27 | 1997-11-12 | Biosistema Di Pier Luigi Spara | Prodotto derivato da latte, sostanzialmente esente da betacaseina di mammifero non umano e relativo uso |
| KR100194074B1 (ko) | 1996-02-21 | 1999-06-15 | 박종헌 | 글루텐 펩타이드를 유효성분으로 포함하는 미네랄 흡수 촉진제 |
| CA2260892A1 (en) | 1996-07-17 | 1998-01-22 | Nicada, Inc. | Appetite suppression |
| KR100221124B1 (ko) | 1996-09-23 | 1999-10-01 | 한상기 | 신규한 카제인 및 그 제조방법 |
| NL1005037C2 (nl) | 1997-01-17 | 1998-07-20 | Nl Zuivelonderzoek Inst | Werkwijze voor het selectief afbreken van melkeiwit, in het bijzonder voor het selectief hydrolyseren van caseïne/caseïnaat in aanwezigheid van andere melkeiwitten, in het bijzonder wei-eiwitten. |
| CA2340223A1 (en) | 1998-08-12 | 2000-02-24 | Morinaga Milk Industry Co., Ltd. | Nutritional compositions for preventing or treating hyperlipoproteinemia |
| JP2000063284A (ja) * | 1998-08-21 | 2000-02-29 | Terumo Corp | 炎症性腸疾患再燃防止剤 |
| US6077558A (en) | 1998-12-23 | 2000-06-20 | Bristol-Myers Squibb Company | Elemental nutritional products |
| US6905702B1 (en) | 1999-11-08 | 2005-06-14 | Children's Hospital Los Angeles | Methods for regulating blood glucose and appetite suppression in type 2 diabetics |
| GB9927603D0 (en) | 1999-11-22 | 2000-01-19 | Nestle Sa | Use of a milk protein hydrolysate in the treatment of diabetes |
| EP1112693B1 (en) | 1999-12-30 | 2006-03-22 | Kerry Group Services Ltd | Composition comprising carbohydrate and peptide material and its use as an energy supplement after or during physical exercise or as a metabolic nutrient for oral consumption |
| NL1014380C2 (nl) | 2000-02-14 | 2001-08-15 | Friesland Brands Bv | Darmwandversterkend voedingsmiddel. |
| US6207638B1 (en) | 2000-02-23 | 2001-03-27 | Pacifichealth Laboratories, Inc. | Nutritional intervention composition for enhancing and extending satiety |
| US7666996B2 (en) | 2000-03-01 | 2010-02-23 | Peptera Pharmaceuticals Ltd | Casein derived peptides and uses thereof |
| IL134830A0 (en) | 2000-03-01 | 2001-05-20 | Chay 13 Medical Res Group N V | Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them |
| TWI268138B (en) | 2000-05-11 | 2006-12-11 | Kanebo Seiyaku Ltd | Composition containing peptide and electrolyte excretion enhancing substance, and food containing the same |
| WO2002000865A1 (fr) | 2000-06-28 | 2002-01-03 | Fuji Nihon Seito Corporation | Nouvelle synthase d'inuline et procede de production d'insuline par cette derniere |
| GB0016189D0 (en) | 2000-06-30 | 2000-08-23 | Pepsyn Ltd | Cosmetic composition |
| WO2002019832A1 (en) | 2000-09-08 | 2002-03-14 | New Zealand Dairy Board | MILK CONTAINING β-CASEIN WITH PROLINE AT POSITION 67 DOES NOT AGGRAVATE NEUROLOGICAL DISORDERS |
| WO2002032231A1 (en) | 2000-10-19 | 2002-04-25 | Edens, Luppo | Protein hydrolysates |
| WO2003005836A2 (en) | 2001-07-10 | 2003-01-23 | Trustees Of Boston University | Modified-fat nutritional products useful for preventing or treating obesity |
| WO2003007730A1 (en) | 2001-07-18 | 2003-01-30 | Dsm Ip Assets B.V. | Process for the hydrolysis of milk proteins |
| DE10149668A1 (de) | 2001-10-09 | 2003-04-10 | Numico Res B V | Insulinmimetische Aminosäuresequenzen |
| JP2003137804A (ja) | 2001-10-31 | 2003-05-14 | Morinaga Milk Ind Co Ltd | インターロイキン−１８誘導剤 |
| DE60218064T2 (de) | 2001-11-21 | 2007-11-15 | Morinaga Milk Industry Co. Ltd. | Neues peptid mit angiotensinkonvertase hemmender wirkung |
| EP1359157A1 (en) | 2002-04-29 | 2003-11-05 | Société des Produits Nestlé S.A. | Metallo-proteinase inhibitory agent |
| US7460960B2 (en) | 2002-05-10 | 2008-12-02 | Epitome Biosystems, Inc. | Proteome epitope tags and methods of use thereof in protein modification analysis |
| US20050256057A1 (en) | 2002-06-04 | 2005-11-17 | Luppo Edens | Protein hydrolysate rich in tripeptides |
| FR2841473B1 (fr) | 2002-06-27 | 2004-09-17 | Ingredia | Utilisation d'au moins un peptide de la caseine s2 a activite inhbitrice de l'enzyme de conversion de l'engiotensine i pour la preparation de medicaments, d'aliments et de complements alimentaires |
| EP1534314B1 (en) | 2002-09-04 | 2014-10-22 | DSM IP Assets B.V. | A nutritional and therapeutic composition of an insulin sensitizer and a peptide fraction |
| TWI317636B (en) | 2002-11-22 | 2009-12-01 | Meiji Dairies Corp | Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress |
| EP1568377A1 (en) | 2002-11-29 | 2005-08-31 | Morinaga Milk Industry Co., Ltd. | Cysteine protease inhibitor |
| EP1589106B1 (en) | 2002-12-29 | 2010-12-01 | Toudai Tlo, Ltd. | Adiponectin receptor and gene coding for the same |
| CA2523410A1 (en) | 2003-05-05 | 2004-11-18 | Unilever Plc | Hydrolysed casein product comprising tripeptides ipp and/or vpp |
| WO2005027953A2 (en) | 2003-09-23 | 2005-03-31 | Dsm Ip Assets B.V. | Use of proline specific endoproteases to hydrolyse peptides and proteins |
| PT1721612E (pt) | 2003-10-24 | 2009-09-02 | Nutricia Nv | Oligossacarídeos imunomoduladores |
| BE1015863A6 (nl) | 2004-01-19 | 2005-10-04 | Huybrechts Lucas | Anticariogene proteinen & peptiden & sacchariden. |
| EP1718158B1 (en) | 2004-01-28 | 2014-07-02 | Andromeda Bio Tech Ltd. | Hsp therapy in conjunction with a low antigenicity diet |
| EP1568707A1 (en) | 2004-02-26 | 2005-08-31 | Puleva Biotech, S.A. | Antihypertensive peptides from casein hydrolysates |
| MXPA06010014A (es) | 2004-03-01 | 2007-03-07 | Peptera Pharmaceuticals Ltd | Peptidos derivados de la caseina y usos terapeuticos de los mismos. |
| KR20070034528A (ko) | 2004-05-27 | 2007-03-28 | 캄피나 네덜란드 홀딩 베.붸. | Ｄｐｐ－ｉｖ 매개 질병의 예방 및／또는 치료용 의약품제조를 위한 단백질 가수분해물의 용도 |
| DE102004040452A1 (de) | 2004-08-20 | 2006-02-23 | N.V. Nutricia | Peptidgemisch |
| KR100560127B1 (ko) | 2004-09-04 | 2006-03-13 | 한국기초과학지원연구원 | 인산화 단백질 분석용 겔-내 표지화 및 겔-내 단리 방법및 이를 이용한 단백질의 인산화 위치 동정 방법 |
| EP1811867A2 (en) | 2004-11-12 | 2007-08-01 | N.V. Nutricia | Food composition comprising a protein- and a lipid fraction for rapidly attenuating inflammatory responses |
| ES2381118T3 (es) | 2004-12-23 | 2012-05-23 | Campina Nederland Holding B.V. | Hidrolizado de proteínas enriquecido en péptidos de inhibición de DPP-IV y su uso |
| CN101106914B (zh) | 2005-01-18 | 2012-12-26 | 帝斯曼知识产权资产管理有限公司 | 营养药物性组合物 |
| EP1843778B1 (en) | 2005-02-03 | 2009-12-23 | DSM IP Assets B.V. | Compositions comprising epigallocatechin gallate and protein hydrolysate |
| ATE425671T1 (de) | 2005-02-09 | 2009-04-15 | Unilever Nv | Lebensmittelprodukte mit hydrolysierten milchfeststoffen mit verbessertem geschmack |
| JP2008539203A (ja) | 2005-04-28 | 2008-11-13 | ディーエスエム アイピー アセッツ ビー．ブイ． | 新規栄養補助組成物 |
| EP1874140B1 (en) | 2005-04-28 | 2011-02-09 | Unilever N.V. | Peptides having a health benefit and compositions comprising them |
| WO2006118459A1 (en) | 2005-04-29 | 2006-11-09 | Campina Nederland Holding B.V. | Antiviral peptides |
| ES2319475B1 (es) | 2005-06-08 | 2010-02-16 | Consejo Superior Investig. Cientificas | Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion. |
| CN101212911B (zh) | 2005-07-01 | 2012-12-05 | 努特里希亚公司 | 含水解的蛋白质的婴儿营养品 |
| GB0523806D0 (en) | 2005-11-23 | 2006-01-04 | Micromass Ltd | Mass spectrometer |
| EP1954299B1 (en) | 2005-11-30 | 2016-01-13 | Campina Nederland Holding B.V. | Use of a protein hydrolysate for enhancing activity of glucagon-like peptide-1 |
| WO2008054192A1 (en) | 2006-11-02 | 2008-05-08 | N.V. Nutricia | Use of nutritional compositions for preventing disorders |
| ATE509624T1 (de) | 2005-12-23 | 2011-06-15 | Nutricia Nv | Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz |
| US20100167979A1 (en) | 2006-02-09 | 2010-07-01 | Calpis Co. Ltd | Rheumatoid arthritis-preventive agent for oral intake |
| WO2007107587A2 (en) | 2006-03-22 | 2007-09-27 | Dsm Ip Assets B.V. | Cholesterol lowering protein hydrolysates |
| EP2003991A1 (en) | 2006-04-12 | 2008-12-24 | DSM IP Assets B.V. | Novel nutraceutical compositions |
| EP2039366A4 (en) | 2006-04-21 | 2010-01-06 | Meiji Seika Kaisha | COMPOSITION CONTAINING PEPTIDE AS ACTIVE INGREDIENT |
| WO2007125946A1 (ja) | 2006-04-28 | 2007-11-08 | Snow Brand Milk Products Co., Ltd. | ペプチド |
| KR20080003637A (ko) | 2006-07-03 | 2008-01-08 | 한상기 | 다이어트효과가 우수한 기능성 유산균발효조성물 |
| US8691213B2 (en) | 2006-08-04 | 2014-04-08 | SHS International | Protein free formula |
| ES2358367T3 (es) | 2006-08-09 | 2011-05-10 | Dsm Ip Assets B.V. | Complejos de caseína. |
| NL1032840C2 (nl) | 2006-11-09 | 2008-05-13 | Friesland Brands Bv | Probiotische hydrolysaatvoeding voor kinderen. |
| NL1033521C2 (nl) | 2007-03-08 | 2008-09-09 | Friesland Brands Bv | Kindervoedingen met geoptimaliseerde aminozuursamenstelling. |
| US20090252729A1 (en) | 2007-05-14 | 2009-10-08 | Farrington Graham K | Single-chain Fc (scFc) regions, binding polypeptides comprising same, and methods related thereto |
| WO2008147562A2 (en) | 2007-05-25 | 2008-12-04 | Childrens's Medical Center Corporation | Dietary formulations and methods for treatment of inflammation and other disorders |
| WO2008153429A2 (en) | 2007-06-11 | 2008-12-18 | Uniwersytet Jagiellonski | A protease from staphylococcus aureus, particularly spia or spib, peptides it recognises and their use |
| CA2699006A1 (en) | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
| EP2230300A4 (en) | 2007-10-24 | 2012-08-08 | Otsuka Chemical Holdings Co Ltd | POLYPEPTIDE WITH IMPROVED EFFECTOR FUNCTION |
| WO2009138762A2 (en) * | 2008-05-15 | 2009-11-19 | Regen Therapeutics Plc | Therapeutic use of peptides |
| US8859210B2 (en) | 2008-10-17 | 2014-10-14 | Mead Johnson Nutrition Company | Method for identifying allergenic proteins and peptides |
| JP5735734B2 (ja) | 2009-04-16 | 2015-06-17 | 雪印メグミルク株式会社 | 脂質代謝改善剤 |
| EP2253324A1 (en) | 2009-04-30 | 2010-11-24 | Consejo Superior De Investigaciones Cientificas | Use of a casein-derived peptide and compositions thereof as antihypertensive |
| EP2295535A1 (en) | 2009-09-11 | 2011-03-16 | Mead Johnson Nutrition Company | Probiotic material |
| ES2524067T3 (es) | 2009-12-04 | 2014-12-03 | Mjn U.S. Holdings Llc | Formulación nutricional que comprende un hidrolizado que contiene péptidos de leche de vaca y/o péptidos derivados del mismo para la inducción de tolerancia |
| BR112012017978A2 (pt) | 2010-01-19 | 2016-05-03 | Abbott Lab | fórmulas nutricionais contendo simbióticos |
| CA2790996A1 (en) | 2010-02-24 | 2011-09-01 | Morinaga Milk Industry Co. Ltd. | Therapeutic agent for eating disorders |
| EP2514435A1 (en) | 2011-04-19 | 2012-10-24 | Nestec S.A. | Infant formula for use in the prevention of cardiovascular diseases |
-
2013
- 2013-03-15 US US13/839,212 patent/US9289461B2/en active Active
-
2014
- 2014-03-11 MX MX2015011927A patent/MX2015011927A/es unknown
- 2014-03-11 CA CA2905817A patent/CA2905817A1/en not_active Abandoned
- 2014-03-11 SG SG11201505692QA patent/SG11201505692QA/en unknown
- 2014-03-11 PE PE2015001891A patent/PE20152003A1/es not_active Application Discontinuation
- 2014-03-11 AU AU2014237022A patent/AU2014237022A1/en not_active Abandoned
- 2014-03-11 BR BR112015017909A patent/BR112015017909A2/pt not_active Application Discontinuation
- 2014-03-11 RU RU2015139557A patent/RU2015139557A/ru unknown
- 2014-03-11 WO PCT/US2014/023630 patent/WO2014150566A1/en active Application Filing
- 2014-03-11 EP EP14717285.2A patent/EP2968438A1/en not_active Withdrawn
- 2014-03-11 CN CN201480015737.9A patent/CN105073126A/zh active Pending
- 2014-03-14 TW TW103109607A patent/TW201521756A/zh unknown
- 2014-03-14 AR ARP140101038A patent/AR095335A1/es unknown
-
2015
- 2015-09-14 PH PH12015502100A patent/PH12015502100B1/en unknown
-
2016
- 2016-05-03 HK HK16104997.7A patent/HK1216994A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2968438A1 (en) | 2016-01-20 |
| CN105073126A (zh) | 2015-11-18 |
| US20140274892A1 (en) | 2014-09-18 |
| PH12015502100A1 (en) | 2016-01-18 |
| BR112015017909A2 (pt) | 2017-11-21 |
| US9289461B2 (en) | 2016-03-22 |
| PE20152003A1 (es) | 2016-01-29 |
| HK1216994A1 (zh) | 2016-12-16 |
| AR095335A1 (es) | 2015-10-07 |
| WO2014150566A1 (en) | 2014-09-25 |
| TW201521756A (zh) | 2015-06-16 |
| MX2015011927A (es) | 2015-12-01 |
| CA2905817A1 (en) | 2014-09-25 |
| AU2014237022A1 (en) | 2015-08-13 |
| SG11201505692QA (en) | 2015-08-28 |
| PH12015502100B1 (en) | 2016-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Donati Zeppa et al. | Mutual interactions among exercise, sport supplements and microbiota | |
| Li et al. | Health benefits of docosahexaenoic acid and its bioavailability: A review | |
| Diez-Gutiérrez et al. | Gamma-aminobutyric acid and probiotics: Multiple health benefits and their future in the global functional food and nutraceuticals market | |
| RU2015139359A (ru) | Способ ослабления провоспалительной реакции | |
| Marion-Letellier et al. | IBD: in food we trust | |
| Stadelmann et al. | Arginine consumption by the intestinal parasite Giardia intestinalis reduces proliferation of intestinal epithelial cells | |
| JP6852980B2 (ja) | 低カロリー高タンパク質の栄養組成物及び該栄養組成物を用いる方法 | |
| RU2015139557A (ru) | Уменьшение риска развития аутоимунного заболевания | |
| Liu et al. | Health benefits, food applications, and sustainability of microalgae-derived N-3 PUFA | |
| Foolchand et al. | Malnutrition and dietary habits alter the immune system which may consequently influence SARS-CoV-2 virulence: a review | |
| Alcock et al. | Fatty acids from diet and microbiota regulate energy metabolism | |
| JP2016516419A (ja) | 同時トレーニングに続いて筋タンパク質合成を高めるための方法 | |
| RU2013146517A (ru) | Композиции и способы, пригодные для облегчения возрастных заболеваний | |
| RU2014150662A (ru) | Диетотерапия целиакии и пищевой аллергии | |
| RU2012139658A (ru) | Композиции и способы для доставки питательных веществ | |
| RU2016140158A (ru) | Лечение аутоиммунной реакции и рассеянного склероза | |
| BR112015032572A2 (pt) | composições e métodos para melhorar o desempenho durante exercícios | |
| Qi et al. | Beta-hydroxybutyrate: a dual function molecular and immunological barrier function regulator | |
| Vilahur et al. | Lactobacillus plantarum CECT 7315/7316 intake modulates the acute and chronic innate inflammatory response | |
| Castro-López et al. | Key stress response mechanisms of probiotics during their journey through the digestive system: a review | |
| Kaur et al. | Weight Loss Associated with High Protein Diet Intake in Obesity: Interactions of Gut Microbiota in Protein Sources Influencing this Positive Effect | |
| RU2013128920A (ru) | Способ ингибирования патогенов с использованием питательной композиции | |
| RU2015133023A (ru) | Активация адипонектина с использованием гидролизата казеина | |
| Ma et al. | Effects of in ovo feeding and dietary addition oils on growth performance and immune function of broiler chickens | |
| Garibotto et al. | How to overcome anabolic resistance in dialysis-treated patients? |